Home › Products › Oncology › Erlogem 150mg Tablet
Erlogem 150mg Tablet
Salt Composition: ERLOTINIB
- Manufacturer: ADMAC LIFE SCIENCES
- Pack Size: 10 TABLET(s) IN A STRIP
- Dosage Form: TABLET
- Strength: 150MG
- Prescription Required
- Storage: Keep out of sight and reach of children. Store at a controlled room temperature between 15°C to 30°C. Do not freeze.
₹2021.00₹6124.00
Inclusive of all taxes
Product Introduction
Erlogem 150 mg Tablet is an anticancer medicine containing erlotinib. It is indicated for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. Cancer is characterised by uncontrolled and abnormal cell multiplication. For patients with metastatic or advanced pancreatic cancer, it is typically administered in combination with gemcitabine.
Inform your doctor if you wear contact lenses, have sugar intolerance, have a history of eye problems, or take medicines for clotting disorders or cholesterol. This medication may cause eye dryness and conjunctivitis; patients should disclose any history of vision problems or contact lens use before commencing treatment. Erlogem 150 mg Tablet is not recommended for children and adolescents under 18 years of age.
Do not take this medication with food. Use effective contraception during treatment and for at least 2 weeks after the final dose. Smoking during treatment with Erlogem 150 mg Tablet should be avoided, as it may reduce blood concentrations of the medicine. Apply protective clothing and sunscreen when outdoors. Inform your doctor if you experience eye pain, blurred vision, cough, fever, shortness of breath, severe abdominal pain, or persistent diarrhoea while taking this medicine.
Uses
Advanced or metastatic non-small lung cancer (NSCLC) Advanced or metastatic pancreatic cancer
How it works
Erlogem 150 mg prevents the activity of a protein called epidermal growth factor receptor (EFGR), a protein involved in the spread and growth of cancer cells.
How to Use
Erlogem 150 mg prevents the activity of a protein called epidermal growth factor receptor (EFGR), a protein involved in the spread and growth of cancer cells.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious: Persistent or severe diarrhea Pain in the eye, blurred vision Sudden difficulty in breathing accompanied by cough and fever Severe pain in your abdomen Liver failure Common: Rash, worsened in sun-exposed areas Loss of appetite, decreased weight Infection Headache Depression Nausea Mouth irritation Indigestion Hair loss, dry skin, itching, acne, cracked skin Tiredness Inflammation around fingernail Bleeding from nose, stomach, intestines Reduced kidney function
Expert Tips
Inform the doctor if you have vision problems, are using contact lenses, have clotting disorders, intolerance to sugar, and taking any medication for cholesterol before starting this medication. This medication should not be taken along with the food, and it can be taken either before or after food as it increases the effectiveness of the medication. It is not recommended for individuals below 18 years of age. Inform the doctor about kidney, and liver disorders as this medication is not recommended in patients with kidney and liver disorders. Avoid making plans to have children or during pregnancy because this medicine is highly unsafe and causes harmful effects on the developing baby.
References
- Goodman & Gilmanâs, The Pharmacological Basis of Therapeutics, Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines, 12th edition, 2011, 1735-1737.
- Mylan, Electronic medicines compendium (emc), [ Revised on Jan 2020] [ Accessed on 14th April 2021], https://www.medicines.org.uk/emc/files/pil.11264.pdf
- Genentech, US Food and Drug Administration, [ Revised on April 2010] [ Accessed on 14th April 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021743s14s16lbl.pdf
Safety Advice
Pregnancy: unsafe Taking Erlogem 150 mg while pregnant can harm the baby. Do not take this medicine during pregnancy unless your doctor recommends taking it. Inform your doctor if you are pregnant or planning to be pregnant before taking this medicine.
Lungs: Consult your doctor It is unknown whether Erlogem 150 mg Tablets affect the lungs. Please consult your doctor.
Breastfeeding: unsafe Do not take Erlogem 150 mg if you are breastfeeding. Consult the doctor for risks and benefits.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.